1. A VP1 mutation acquired during an enterovirus 71 disseminated infection confers heparan sulfate binding ability and modulates ex vivo tropism
- Author
-
Luc Stoppini, Eirini Tseligka, Fabien Abdul, Komla Sobo, Caroline Tapparel, Isabelle Piuz, Samuel Constant, Pascal Meylan, Valeria Cagno, and Song Huang
- Subjects
0301 basic medicine ,Pulmonology ,Cell Lines ,Heparitin Sulfate/metabolism ,Virus Replication ,Binding Analysis ,Mice ,chemistry.chemical_compound ,Animals ,Capsid Proteins/genetics ,Enterovirus A, Human/pathogenicity ,Enterovirus A, Human/physiology ,Hand, Foot and Mouth Disease/genetics ,Hand, Foot and Mouth Disease/metabolism ,Hand, Foot and Mouth Disease/virology ,Humans ,Lysosome-Associated Membrane Glycoproteins/metabolism ,Mutation ,Receptors, Scavenger/metabolism ,Viral Tropism/genetics ,Virus Replication/genetics ,Animal Cells ,Medicine and Health Sciences ,Enterovirus 71 ,lcsh:QH301-705.5 ,ddc:616 ,Neurons ,Receptors, Scavenger ,education.field_of_study ,Heparan sulfate ,3. Good health ,Biological Cultures ,Anatomy ,Cellular Types ,Cell Binding Assay ,Research Article ,lcsh:Immunologic diseases. Allergy ,Hand, Foot and Mouth Disease/genetics/metabolism/virology ,Cell Binding ,Cell Physiology ,Immunology ,Population ,Biology ,Research and Analysis Methods ,Microbiology ,Virus ,03 medical and health sciences ,Virology ,Genetics ,education ,Molecular Biology ,Chemical Characterization ,Tropism ,Biology and Life Sciences ,Lysosome-Associated Membrane Glycoproteins ,Cell Biology ,biology.organism_classification ,Enterovirus A, Human/pathogenicity/physiology ,Viral Replication ,Enterovirus A, Human ,Gastrointestinal Tract ,Viral Tropism ,030104 developmental biology ,lcsh:Biology (General) ,Viral replication ,chemistry ,Cellular Neuroscience ,Respiratory Infections ,Tissue tropism ,Capsid Proteins ,Parasitology ,Heparan sulfate binding ,Heparitin Sulfate ,Caco-2 Cells ,lcsh:RC581-607 ,Hand, Foot and Mouth Disease ,Digestive System ,Neuroscience - Abstract
Enterovirus 71 (EV71) causes hand, foot and mouth disease, a mild and self-limited illness that is sometimes associated with severe neurological complications. EV71 neurotropic determinants remain ill-defined to date. We previously identified a mutation in the VP1 capsid protein (L97R) that was acquired over the course of a disseminated infection in an immunocompromised host. The mutation was absent in the respiratory tract but was present in the gut (as a mixed population) and in blood and cerebrospinal fluid (as a dominant species). In this study, we demonstrated that this mutation does not alter the dependence of EV71 on the human scavenger receptor class B2 (SCARB2), while it enables the virus to bind to the heparan sulfate (HS) attachment receptor and modifies viral tropism in cell lines and in respiratory, intestinal and neural tissues. Variants with VP197L or VP197R were able to replicate to high levels in intestinal and neural tissues and, to a lesser extent, in respiratory tissues, but their preferred entry site (from the luminal or basal tissue side) differed in respiratory and intestinal tissues and correlated with HS expression levels. These data account for the viral populations sequenced from the patient’s respiratory and intestinal samples and suggest that improved dissemination, resulting from an acquired ability to bind HS, rather than specific neurotropism determinants, enabled the virus to reach and infect the central nervous system. Finally, we showed that iota-carrageenan, a highly sulfated polysaccharide, efficiently blocks the replication of HS-dependent variants in cells and 2D neural cultures. Overall, the results of this study emphasize the importance of HS binding in EV71 pathogenesis and open new avenues for the development of antiviral molecules that may prevent this virus’s dissemination., Author summary Enterovirus 71 (EV71) has been the cause of major hand-foot-and-mouth disease outbreaks, particularly in the Asia-Pacific region. However, the recent emergence of severe neurological cases associated with EV71 infection in Europe and the lack of an efficient vaccine or antiviral agent to fight EV71 infections highlight two critical needs: (A) the identification of ill-defined viral factors that contribute to viral dissemination and pathogenesis in humans and (B) the development of effective antiviral strategies. Herein, based on clinical observation in an immunocompromised host, we have demonstrated that heparan sulfate attachment receptor played a critical role in EV71 virulence and that “in host” EV71 adaptation to a heparan sulfate-dependent virus was likely responsible for its dissemination. To our knowledge, this is the first study highlighting the key determinants of EV71 dissemination based on a clinical case and proposing a new therapeutic approach against EV71 neurological diseases.
- Published
- 2018